Kaio Therapy, LLC

Kaio`s strategy is to develop and in-license technologies and therapies that enable the body’s own immune system to work more efficiently. The goal is to improve clinical outcomes for patients, increase the number and efficacy of therapeutic options available to patients, eliminating adverse events common to other forms of cancer therapies, minimizing adverse events when used in combination with other therapies, reducing costs, and do all of this naturally. Headquartered in Raleigh, NC, Kaio Therapy, LLC is focused on the development of novel active immunotherapy platforms.